Upstate

Uridine,2′-deoxy-;2′-Deoxyuridine;Deoxyuridine;Uracil deoxyriboside;2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-β-D-erythro-pentofuranosyl)-;2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-β-D-ribofuranosyl)-;Deoxyribose uracil;2′-Desoxyuridine;1-(2-Deoxy-β-D-erythro-pentofuranosyl)uracil;NSC 23615;20649-53-0

10H-Phenothiazine,2-(trifluoromethyl)-;Phenothiazine,2-(trifluoromethyl)-;2-(Trifluoromethyl)-10H-phenothiazine;2-(Trifluoromethyl)phenothiazine;NSC 50438

Nerve growth factor;Nerve growth hormone;NGF;Neurotrophin 1;Nerve growth factors;NsG 0202

Ac-Ile-Glu-Thr-Asp-PNA;219138-21-3;AC-IETD-PNA;(4S)-4-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-5-[[(2S,3R)-1-[[(2S)-3-carboxy-1-(4-nitroanilino)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid;SCHEMBL4594304;Caspase-8 Chromogenic Substrate I;MFCD01318840;ZINC150341012;HY-120833;CS-0079281

CASPASE-6 SUBSTRATE II, COLORIMETRIC;CASPASE-6 SUBSTRATE (CHROMOGENIC);CASPASE 6 (MCH2) SUBSTRATE 1, CHROMOGENIC;AC-VAL-GLU-ILE-ASP-PARANITROANILIDE;AC-VAL-GLU-ILE-ASP-PNA;AC-VEID-PNA;N-ACETYL-VAL-GLU-ILE-ASP-P-NITROANILIDE;N-ACETYL-VAL-GLU-ILE-ASP-P-NITROANILIDE PNA

Adenosine 5′-(tetrahydrogen triphosphate);Adenosine 5′-triphosphate;Adenosine triphosphate;Adenosine 5′-triphosphoric acid;Atipi;ATP (nucleotide);5′-ATP;Atriphos;Striadyne;Triphosphoric acid adenosine ester;Adenylpyrophosphoric acid;Adetol;Triadenyl;Adephos;Triphosphaden;Adynol;Glucobasin;ATP;Cardenosine;Adenosine,5′-(tetrahydrogen triphosphate);Fosfobion;Myotriphos;Phosphobion;5: PN: WO2010069064 FIGURE: 3A claimed sequence;Adenosine-5′-triphosphate;10168-83-9;16488-07-6;51569-41-6;71800-44-7;84412-18-0;896506-78-8;917074-14-7;1259312-93-0

(E)-2-CYANO-3-(3,4-DIHYDROPHENYL)-N-(PHENYLMETHYL)-2-PROPENAMIDE;ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE;AG 490;A-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMAMIDE;A-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE;2-CYANO-3-[3,4-DIHYDROXYPHENYL]-N-[PHENYLMETHYL]-2-PROPENAMIDE;N-BENZYL-3,4-DIHYDROXY-ALPHA-CYANOCINNAMIDE;N-BENZYL-3,4-DIHYDROXY-BENZYLIDENECYANOACETAMIDE

MAP KINASE SUBSTRATE PEPTIDE;MBP (95-98) S5 PEPTIDE;MBP MAPK SUBSTRATE;H-ALA-PRO-ARG-THR-PRO-GLY-GLY-ARG-ARG-OH;APRTPGGRR;ALA-PRO-ARG-THR-PRO-GLY-GLY-ARG-ARG;ALA-PRO-ARG-THR-PRO-GLY-GLY-ARG-ARG S5;SUBSTRATE FOR P44MPK THE MEIOSIS-ACTIVATED

Oxacyclohexadeca-3,5,11,13-tetraen-2-one,8-hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-,(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-;Hygrolidin,21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methyl-;Oxacyclohexadecane,hygrolidin deriv.;(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-8-Hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one;Bafilomycin A1;Oxacyclohexadeca-3,5,11,13-tetraen-2-one,8-hydroxy-16-[2-hydroxy-1-methyl-3-[tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-,[7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*[1S*,2R*,3S*(2R*,4R*,5S*,6R*)]]]-;(-)-Bafilomycin A1;NSC 381866

Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium,inner salt;Pyridinium,3-carbamoyl-1-β-D-ribofuranosyl-,hydroxide,5′→5′-ester with adenosine 5′-(trihydrogen pyrophosphate),inner salt;Adenosine 5′-(trihydrogen diphosphate),P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium hydroxide,inner salt;Codehydrase I;Codehydrogenase I;Coenzyme I;Diphosphopyridine nucleotide;DPN;Cozymase I;NAD;Nadide;Nicotinamide-adenine dinucleotide;Oxidized diphosphopyridine nucleotide;Adenine-nicotinamide dinucleotide;NAD+;Enzopride;β-NAD;β-Diphosphopyridine nucleotide;β-Nicotinamide adenine dinucleotide;β-NAD+;NSC 20272;CO-I;β-Nicotinamide adenine dinucleotide hydrate;30429-30-2;159929-29-0;1083039-67-1;1354693-98-3

BOVINE FIBROBLAST GROWTH FACTOR ACIDIC;BOVINE FGF;BOVINE FGF ACIDIC;HUMAN FIBROBLAST GROWTH FACTOR ACIDIC;HUMAN FGF-ACIDIC;FIBROBLAST GROWTH FACTOR, BOVINE;FGF-ACIDIC (HUMAN);FGF-ACIDIC PEPTIDE

HUMAN BRAIN-DERIVED NEUROTROPHIC FACTOR;HUMAN BDNF;BDNF;BDNF (HUMAN);BNDF;BRAIN-DERIVED NEUROTROPHIC FACTOR;BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN;BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN, RECOMBINANT

Uridine,5-bromo-2′-deoxy-;5-Bromo-2′-deoxyuridine;5-BDU;BDU;Bromodeoxyuridine;5-Bromodeoxyuridine;5-Bromouracil deoxyriboside;BUdR;5-Bromodesoxyuridine;Broxuridine;NSC 38297;BrdUrd;5-Bromo-2′-desoxyuridine;2′-Deoxy-5-bromouridine;BRUDR;5-Bromouracil-2-deoxyriboside;(+)-5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;BrdU;5-Bromouracil-2′-deoxyriboside;723-73-9;3445-26-9;1236362-78-9

Acetamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;Acetamide,N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-,(E)-D-erythro-;Acetamide,N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-,[R-[R*,S*-(E)]]-;Acetamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-;N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]acetamide;N-Acetyl-C18-sphingosine;D-erythro-1,3-Dihydroxy-2-acetamido-trans-4-octadecene;N-Acetylsphingosine;D-erythro-C2-Ceramide;C2-Ceramide;D-erythro-N-Acetylsphingosine;N-Acetyl-D-erythro-sphingosine;N-Acetyl-D-sphingosine;Ceramide 2;532-45-6

CAN;PP2B;PPASE-2B;CALCINEURIN;CALCINEURIN/PP2B;CALCINEURIN, HUMAN;PROTEIN PHOSPHATASE 2B;Calcineurin bovine brain;MODULATOR BINDING PROTEIN;CALMODULIN BINDING PROTEIN

PHOSPHODIESTERASE 3':5'-CYCLIC NUCLEOTIDE ACTIVATOR (HUMAN);PHOSPHODIESTERASE 3,5'-CYCLIC-NUCLEOTIDE ACTIVATOR;PHOSPHODIESTERASE 3':5'-CYCLIC NUCLEOTIDE-ACTIVATOR;PHOSPHODIESTERASE 3'5'-CYCLIC NUCLEOTIDE-ACTIVATOR;PHOSPHODIESTERASE 3':5'-CYCLIC NUCLEOTIDE ACTIVATOR BOVINE;CA2+/CALMODULIN, BOVINE;CA2+/CALMODULIN, HUMAN;CALMODULIN

L-Ribonamide,N-[(3S)-3-[4-[(1E)-3-[(2R,3R,5R,7S,8S,9R)-2-[(1S,3S,4S,5R,6R,7E,9E,11E,13Z)-14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyl-7,9,11,13-tetradecatetraen-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]-1-propen-1-yl]-2-oxazolyl]butyl]-4-deoxy-4-(dimethylamino)-5-O-methyl-;L-Ribonamide,N-[3-[4-[3-[2-(14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyl-7,9,11,13-tetradecatetraenyl)-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]-1-propenyl]-2-oxazolyl]butyl]-4-deoxy-4-(dimethylamino)-5-O-methyl-,[5R-[5α[2R*(1S*,3S*,4S*,5R*,6R*,7E,9E,11E,13Z),3R*],7β[E(S*)],8β,9α]]-;L-Ribonamide,N-[(3S)-3-[4-[(1E)-3-[(2R,3R,5R,7S,8S,9R)-2-[(1S,3S,4S,5R,6R,7E,9E,11E,13Z)-14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyl-7,9,11,13-tetradecatetraenyl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]-1-propenyl]-2-oxazolyl]butyl]-4-deoxy-4-(dimethylamino)-5-O-methyl-;1,6-Dioxaspiro[4.5]decane,L-ribonamide deriv.;N-[(3S)-3-[4-[(1E)-3-[(2R,3R,5R,7S,8S,9R)-2-[(1S,3S,4S,5R,6R,7E,9E,11E,13Z)-14-Cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyl-7,9,11,13-tetradecatetraen-1-yl]-9-hydroxy-4,4,8-trimethyl-3-(phosphonooxy)-1,6-dioxaspiro[4.5]dec-7-yl]-1-propen-1-yl]-2-oxazolyl]butyl]-4-deoxy-4-(dimethylamino)-5-O-methyl-L-ribonamide;Calyculin A;(-)-Calyculin A

Protein serine/threonine kinase;Kinase (phosphorylating),protein serine/threonine;E.C. 2.7.1.37;EC 2.7.1.37;Serine/threonine protein kinase;Serine protein kinase;Protein serine kinase;Serine/threonine-specific protein kinase;Serine kinase;Threonine protein kinase;Serine/threonine phosphokinase;Protein serine/threonine kinase (phosphorylating);Threonine kinase;Serine/threonine kinase;E.C. 2.7.11.1;Ser/Thr protein kinase;Protein serine/threonine kinase inhibitors;Protein serine/threonine kinases;Serine/threonine kinases;EC 2.7.11.1;117056-44-7;117277-98-2;117590-74-6;121855-01-4;121855-02-5;122007-71-0;122544-57-4;123057-66-9;123175-71-3;129430-48-4;139074-23-0;143515-33-7;144999-29-1

ANTI-MOUSE CSNK2A2 (N-TERM) antibody produced in rabbit;Csnk2a2;Anti-Casein Kinase II α antibody produced in rabbit;CK2-α1;CKIIA;CSK21;Anti-CKII-β, C-Terminal antibody produced in rabbit;CK2N

PROCASPASE-3;PROCASPASE-3, HIS TAG(R) HUMAN;PROCASPASE-3, HIS TAG(R), MOUSE;PROCASPASE-3 (HUMAN);PRO-CASPASE-3 (HUMAN) (REC);PRO-CASPASE-3 (HUMAN) (RECOMBINANT);PROCASPASE-3, HUMAN, RECOMBINANT, E COLI;YAMA